Envista (NYSE:NVST) Releases Earnings Results, Beats Expectations By $0.06 EPS

Envista (NYSE:NVST) released its quarterly earnings results on Thursday. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.32 by $0.06, FiscalAI reports. Envista had a net margin of 0.58% and a return on equity of 5.90%. Envista updated its FY 2026 guidance to 1.350-1.450 EPS.

Envista Price Performance

NYSE NVST traded up $1.15 during trading hours on Thursday, reaching $24.81. The company’s stock had a trading volume of 9,025,715 shares, compared to its average volume of 2,933,734. The company has a quick ratio of 2.02, a current ratio of 2.37 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $4.08 billion, a price-to-earnings ratio of 275.66, a PEG ratio of 1.02 and a beta of 1.01. Envista has a 1 year low of $14.22 and a 1 year high of $25.41. The firm’s 50-day moving average price is $22.56 and its 200-day moving average price is $21.14.

Wall Street Analysts Forecast Growth

NVST has been the subject of several recent research reports. JPMorgan Chase & Co. boosted their price objective on Envista from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Tuesday, December 16th. Weiss Ratings restated a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Piper Sandler raised their price objective on shares of Envista from $19.00 to $21.00 and gave the stock a “neutral” rating in a report on Friday, January 30th. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. Finally, Barclays assumed coverage on shares of Envista in a report on Monday, December 8th. They issued an “overweight” rating and a $24.00 price target on the stock. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $22.75.

Hedge Funds Weigh In On Envista

Several institutional investors have recently bought and sold shares of NVST. Mariner LLC raised its stake in Envista by 19.7% in the third quarter. Mariner LLC now owns 13,761 shares of the company’s stock valued at $280,000 after buying an additional 2,264 shares during the last quarter. Mercer Global Advisors Inc. ADV lifted its position in Envista by 101.7% during the third quarter. Mercer Global Advisors Inc. ADV now owns 20,921 shares of the company’s stock valued at $426,000 after purchasing an additional 10,547 shares during the period. Landscape Capital Management L.L.C. acquired a new stake in Envista during the 3rd quarter worth about $429,000. Captrust Financial Advisors raised its stake in shares of Envista by 38.4% during the 2nd quarter. Captrust Financial Advisors now owns 15,465 shares of the company’s stock valued at $302,000 after buying an additional 4,290 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new position in Envista during the second quarter valued at approximately $318,000.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.